Time to Protection and Adherence Requirements of Raltegravir With or Without Lamivudine in Protection From HIV Infection

Condition:   Hiv Interventions:   Drug: Raltegravir 400Mg Tab;   Drug: Lamivudine 150Mg Tablet Sponsor:   Guy's and St Thomas' NHS Foundation Trust Not yet recruiting - verified June 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Isentress